LustGarden Foundation for Pancreatic Cancer Research

World Class Research

As the largest private funder of pancreatic cancer research, we are relentlessly focused on improving patient outcomes and we are making progress every day. Thanks to separate funding to support administrative expenses, 100 percent of every donation goes directly to research.

Navigating Pancreatic Cancer

We are here to empower you to ask bold questions, seek out the best treatment options, and face the unique challenges of pancreatic cancer head-on. We want to give you the resources and information you need to make informed decisions that are best for you.

Patient Checklist

Checklist

August 1, 2018 ladmin

As overwhelming as a pancreatic cancer diagnosis is, it is important to act quickly and put a treatment plan into place. Treatment should ideally begin within one month after you receive your diagnosis. Understand your disease. Thoroughly understand what stage of pancreatic cancer you have and inquire about having your blood and tumor genetically sequenced. […]

Research

Clinical Trials Finder

July 30, 2018 ladmin

If you have been diagnosed with pancreatic cancer, a clinical trial may be your best treatment option. Many clinical trials are underway for patients in all stages of the disease and may involve new combinations of currently available drugs or new drugs that have worked in other cancers. No matter where you are in your journey, we encourage you to learn more about clinical trials.

Lets Win! Pancreatic Cancer

Let’s Win! Pancreatic Cancer

July 20, 2018 ladmin

LET’S WIN! Pancreatic Cancer A Dynamic Way to Share Information Recognizing that there is an urgent need for patients to communicate amongst themselves and with the medical community about potentially life-changing treatments and clinical trials, we are proud to be affiliated with Let’s Win. Let’s Win is an interactive online community where patients and families […]

Pancreatic Cancer Connections

July 7, 2018 ladmin

Pancreatic Cancer Connections is online social community that provides a safe space for pancreatic cancer patients and their loved ones to share their experiences, get valuable coping resources, and support one another. Patients interact with others who are facing a pancreatic cancer and can post questions to the board or message other members privately. This community forum is a valuable resource for patients, caregivers, and their loved ones to refer to at various stages of their treatment and recovery.

Patients and loved ones can sign up for Pancreatic Cancer Connections at no cost and will be welcomed into an engaging and supportive community to discuss topics including treatment options, nutrition, and coping with the disease. Pancreatic Cancer Connections is hosted by Inspire, a leading healthcare social network that connects more than 1,000,000 patients and caregivers.

Lustgarten News

View All Articles

New Chief Medical Advisor

Internationally Renowned Cancer Immunologist Elizabeth M. Jaffee, M.D. Joins the Lustgarten Foundation

The Lustgarten Foundation announced today the appointment of Elizabeth M. Jaffee, M.D., the immediate past president of the American Association for Cancer Research (AACR), as its new Chief Medical Advisor. Dr. Jaffee is an internationally recognized expert in cancer immunology, with specific expertise in preclinical and early clinical development of immunotherapies for pancreatic cancer.

Learn More

Funding Artificial Intelligence Research

New Tools For Detecting and Treating Pancreatic Cancer

Collective logoThe Pancreatic Cancer Collective, the strategic partnership of Lustgarten Foundation and Stand Up To Cancer (SU2C) is funding two new million-dollar grants for computational approaches to identifying high-risk pancreatic cancer populations. The grant money will be used to develop new ways of identifying people who are at high risk for developing pancreatic cancer that will be based on their health records.

Artificial intelligence (AI) is a term that refers to machines that are programmed to mimic human reasoning. The goal of AI is to learn from failure and be able to provide the best recommendation for a specific subject. Whether it be solving equations, finding the best treatment options for cancer patients, or aiding in vehicle autonomy, AI is becoming a powerful resource across multiple industries.

“From diagnosing pancreatic cancer to determining which treatment approach may be best for each patient, we believe the field of AI holds great promise for patients and their families,” stated David A. Tuveson, MD, PhD, Lustgarten’s chief scientist, director of the Cancer Center at Cold Spring Harbor Laboratory and co-scientific leader of the Collective.

The two teams will each pursue a different approach to identifying individuals in the general population who are at high risk for pancreatic cancer. One will use molecular and genetic data taken from a variety of datasets to identify new and accessible ways to identify high-risk individuals. The other focuses on identification of high-risk individuals by applying machine learning analysis to real world data comprising radiological images, electronic medical records, and information collected by physicians. Each team will receive up to $1 million over two years.

 

Related Topics:

Learn more about the Pancreatic Cancer Collective
Find a screening program 

 

 

Learn More

Northwell Health Announces Sponsorship

Northwell Health a Presenting Sponsor of Five Walks

We are pleased to announce that Northwell Health Cancer Institute will be a presenting sponsor for our five Lustgarten Pancreatic Cancer Research Walks in the New York metropolitan area. With the support of Northwell Health, we will raise even more awareness and funding for pancreatic cancer research at our upcoming walks in New York City, Westchester, Brooklyn, Staten Island, and Long Island.

Our walks offer patients, survivors, and loved ones a day of hope where everyone is united in the shared goal of bringing awareness to this challenging disease. Together with Northwell Health, we are determined to raise critical funds for pancreatic cancer research and improve the survival outcomes for patients.

Northwell Sponsorship LI WalkThe Northwell Health Cancer Institute is in the early stages of developing a comprehensive pancreatic cancer center. The program’s major components will include surgical, radiation and medical oncology, interventional gastroenterology, pathology, radiology, endocrinology, palliative oncology, cancer genetics, nutritional counseling, social work and other services.

If you live in the New York metropolitan area, we encourage you to attend one of our five Northwell Health-sponsored walks, visit the Northwell Health tent on site, and learn more about our joint commitment to  changing patients’ lives and working toward a cure for pancreatic cancer.

Read the press release.

Learn more about pancreatic cancer, including information on diagnosis, treatment options, and clinical trials.

Walk For Research

Where 100% of Every Dollar Raised Goes Directly to Pancreatic Cancer Research.

New York City  |  March 31st
Pier 62-63 at Hudson River Park

Register Now!

Westchester  |  April 28th
Rye Playland Park

Register Now!

Brooklyn  |  July 21st
Marine Park Carmine Carro Center

Register Now!

Staten Island  |  September 8th
Franklin D. Roosevelt Boardwalk Beach

Register Now!

Long Island  |  October 6th
Jones Beach State Park

Register Now!

Learn More

Pancreatic Cancer News

View All Articles

The fluid that feeds tumor cells

16. 4. 19 ladmin

Before being tested in animals or humans, most cancer drugs are evaluated in tumor cells grown in a lab dish. However, in recent years, there has been a growing realization that the environment in which these cells are grown does not accurately mimic the natural environment of a tumor, and that this discrepancy could produce […]

Genome-Wide Analysis Reveals New Strategies to Target Pancreatic Cancer

4. 4. 19 ladmin

For some cancers, initial treatment with chemotherapy brings positive, but only temporary, results: tumors shrink, but then rebound as the cancer becomes drug-resistant. This pattern of remission-resistance-relapse is particularly true for pancreatic cancer, an aggressive disease in which early success is often countered by eventual disease progression. To wit: The one-year relative survival rate for […]

Mayo Clinic finds 3 factors may extend life for pancreatic cancer patients

2. 4. 19 ladmin

 A new study from the Mayo Clinic found that a pre-surgery treatment plan may help extend life for advanced pancreatic cancer patients. According to Mayo researchers, most pancreatic cancer patients whose tumors grow outside the pancreas and encompass veins and arteries have been told the cancer is inoperable and they should prepare for an average survival time of 12 to 18 months. […]

Pancreatic Cancer Survival Odds Linked to Weight Before Age 50

1. 4. 19 ladmin

Need another reason to stay slim? People who are overweight have a greater risk of dying from pancreatic cancer, especially those who are carrying extra pounds before age 50, a new study suggests. “No matter what the age, there was some increase in pancreatic cancer deaths associated with excess weight. But the association was stronger […]

Trial to assess high-dose, MRI-guided radiation therapy for pancreatic cancer

30. 3. 19 ladmin

Researchers are launching a multi-institutional trial to test the effectiveness of precise, higher dose, MRI-guided radiation therapy to treat pancreatic cancer. “High-definition MRI and daily treatment plan adaptation allow us to deliver ablative radiation doses safely to [patients with pancreatic cancer] for the first time,” Parag Parikh, MD, director of gastrointestinal radiation oncology and MRI-guided […]

The Pancreatic Cancer Collective Funds Two New Research Teams Using Artificial Intelligence To Identify High-Risk Pancreatic Cancer Populations

30. 3. 19 ladmin

Computational Tools Seek to Identify Pancreatic Cancer Earlier, Provide More Opportunities for Timely, Effective Treatments The Pancreatic Cancer Collective, the strategic partnership of Lustgarten Foundation and Stand Up To Cancer (SU2C), today announced two, million-dollar grants for computational approaches to identifying high-risk pancreatic cancer populations. The grant money will be used to develop novel tools […]

Tumor-associated immune cells hinder frontline chemotherapy drug in pancreatic cancer

26. 3. 19 ladmin

A frontline chemotherapy drug given to patients with pancreatic cancer is made less effective because similar compounds released by tumor-associated immune cells block the drug’s action, research led by the University of Michigan Rogel Cancer Center found. The chemotherapy drug gemcitabine is an anti-metabolite. It’s similar to normal metabolites taken up by the cell, but […]

Early Detection Is Possible for Pancreatic Cancer

15. 3. 19 ladmin

We can help people at risk, but it is much more challenging if most people think that early detection and prevention are impossible. Pancreatic cancer has a bad reputation. It is a terrible disease, but most people do not realize there are ways that early detection can help. When the “Jeopardy!” host, Alex Trebek, announced […]

Back to Top